Clinical trials
Aortic Valve Stenosis trials in Belgium with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Corcym S.r.l | 4 |
| Abbott Medical Devices | 2 |
| Anteris Technologies Ltd. | 2 |
| AorticLab Srl | 1 |
| Biotronik AG | 1 |
| Clinical Centre of Serbia | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Edwards Lifesciences | 1 |
| Grena Biomed Limited | 1 |
| Hasselt University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aortic Valve Stenosis | 22 |
| Aortic Valve Disease | 6 |
| Heart Valve Diseases | 6 |
| Aortic Valve Insufficiency | 4 |
| Cardiovascular Diseases | 3 |
| Heart Diseases | 3 |
| Aneurysm, Aortic Arch | 1 |
| Aneurysm, Ascending Aorta | 1 |
| Aortic Aneurysm | 1 |
| Aortic Aneurysm, Abdominal | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.